The Research Institutions and Academic Centers end-user segment is a foundational component of the entire Longevity field, serving as the essential, high-volume consumer of specialized research products and the primary source of novel therapeutic targets. These institutions are conducting the basic, non-commercialized geroscience research that identifies the fundamental mechanisms and pathways...
Technological innovation is at the heart of the growth within the Longevity segment, with Artificial Intelligence (AI) and advanced Biomarker Testing leading the transformation toward personalized health management. AI algorithms are crucial for analyzing the massive, complex datasets generated by genomics, proteomics, and wearable devices. By processing this data, AI can effectively predict...
In early 2026, the concept of "Biological Age" has moved from the lab to the mainstream "Longevity Clinic." The primary tool for this is the "Epigenetic Clock," which measures "DNA Methylation" patterns—the chemical "tags" that turn genes on or off as we age. Unlike your chronological age, your "Bio-Age" is a biomarker of how well your cells are actually functioning. In early 2026, these...
The Wearable Technology and Digital Health product category is a key accelerator of mainstream longevity adoption, democratizing access to crucial health data and empowering individuals to proactively manage their aging process. This segment includes smartwatches, fitness trackers, sleep monitors, and dedicated metabolic health devices (like continuous glucose monitors, or CGMs) that...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai 
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china